Summit Partners Public Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-121,117	Closed	-$11.8M	–	77
2023 Q1	$11.8M	Sell	121,117 -74,549	-38%	-$7.25M	0.48%	53
2022 Q4	$20.2M	Buy	195,666 +195,357	+63,222%	+$20.2M	1.28%	32
2022 Q3	$26K	Buy	+309	New	+$26K	﹤0.01%	59